Prolonged targeted temperature management compromises thrombin generation:A randomised clinical trial

Autor: Anders Morten Grejs, Susanne Ilkjær, Anne-Mette Hvas, Christophe Henri Valdemar Duez, Anni Nørgaard Jeppesen, Hans Kirkegaard
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Zdroj: Jeppesen, A N, Hvas, A-M, Duez, C H V, Grejs, A M, Ilkjær, S & Kirkegaard, H 2017, ' Prolonged targeted temperature management compromises thrombin generation : A randomised clinical trial ', Resuscitation, vol. 118 . https://doi.org/10.1016/j.resuscitation.2017.06.004
DOI: 10.1016/j.resuscitation.2017.06.004
Popis: AIM: To investigate whether prolonged compared with standard duration of targeted temperature management (TTM) compromises coagulation.METHODS: Comatose survivors after out-of-hospital cardiac arrest (n=82) were randomised to standard (24h) or prolonged (48h) duration of TTM at 33±1°C. Blood samples were drawn 22, 46 and 70h after attaining the target temperature. Samples were analysed for rotational thromboelastometry (ROTEM(®) (EXTEM(®), INTEM(®), FIBTEM(®) and HEPTEM(®))) and thrombin generation using the Calibrated Automated Thrombogram(®) assay.RESULTS: With the 22-h sample, we revealed no difference between groups in the ROTEM(®) and thrombin generation results beside a slightly higher EXTEM(®) and INTEM(®) maximum velocity in the prolonged group (p-values≤0.04). With the 46-h sample, ROTEM(®) showed no differences when using EXTEM(®); however, 11% (pCONCLUSION: Prolonged TTM in post-cardiac arrest patients impairs thrombin generation. ClinicalTrials.gov identifier: NCT02258360.
Databáze: OpenAIRE